Sign in
4

Changes in Ownership

Ovid Therapeutics Inc. Filed Acc 0001209191-20-064645

Options or other derivatives

  • EVP,Finance & Corp. Controller acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Daly Timothy EVP,Finance & Corp. Controller 2020-12-17 Grant or award · Stock Option (Right to Buy) +125,000 125,000 D
Loading xslF345X03/doc4.xml…